Page 120 - Human Lyme Neuroborreliosis
P. 120

104 David S. Younger

those most affected and complicated cases with evidence of altered immunity.
Early treatment and prevention are the mainstays of treatment in those with
early Lyme disease to forestall neurological involvement.

                          References

[1] Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment,
       treatment, and prevention of Lyme disease, human granulocytic
       Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the
       Infectious Diseases Society of America. Clin Infect Dis 2006; 43:1089-
       1134.

[2] Halperin JJ, Logigian E, Finkel M, et al. Practice parameters for the
       diagnosis of patients with nervous system Lyme borreliosis (Lyme
       disease). Neurology 1996; 46:619-627.

[3] Dattwyler RJ, Halperin JJ, Volkman DJ et al. Treatment of late Lyme
       borreliosis-randomised comparison of ceftriaxone and penicillin. Lancet
       1988; 1:1191-1194.

[4] Steere AC, Pachner AR, Malawista SE. Neurologic abnormalities of
       Lyme disease: successful treatment with high-dose intravenous
       penicillin. Ann Intern Med 1983; 99:767-772.

[5] Pfister HW, Preac-Mursic V, Wilske B, et al. Cefotaxime vs. penicillin
       G for acute neurologic manifestations in Lyme borreliosis. A prospective
       randomized study. Arch Neurol 1989; 46:1190-1194.

[6] Karlsson M, Hammers-Berggren S, Lindquist L, et al. Comparison of
       intravenous penicillin G and oral doxycycline for treatment of Lyme
       neuroborreliosis. Neurology 1994; 44:1203-1207.

[7] Halperin JJ, Shapiro ED, Logigian E, et al.; Quality Standards
       Subcommittee of the American Academy of Neurology. Practice
       parameter: treatment of nervous system Lyme disease (an evidence-
       based review): report of the Quality Standards Subcommittee of the
       American Academy of Neurology. Neurology 2007; 69:91-102.

[8] Berglund J, Stjernberg L, Ornstein K, et al. 5-year follow-up study of
       patients with neuroborreliosis. Scand J Infect Dis 2002; 34:421-425.

[9] Krbkova L, Stanek G. Therapy of Lyme borreliosis in children. Infection
       1996; 24:170-173.

[10] Borg R, Dotevall L, Hagberg L, et al. Intravenous ceftriaxone compared
       with oral doxycycline for the treatment of Lyme neuroborreliosis. Scand
       J Infect Dis 2005; 37:449-454.

           Complimentary Contributor Copy
   115   116   117   118   119   120   121   122   123   124   125